nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—migraine—Prednisone—Crohn's disease	0.917	1	CpDpCtD
Ergotamine—HTR2A—enteric nervous system—Crohn's disease	0.000937	0.303	CbGeAlD
Ergotamine—HTR2A—myenteric nerve plexus—Crohn's disease	0.00071	0.23	CbGeAlD
Ergotamine—ADRA1D—epithelium—Crohn's disease	0.00019	0.0616	CbGeAlD
Ergotamine—HTR2B—smooth muscle tissue—Crohn's disease	0.000128	0.0413	CbGeAlD
Ergotamine—HTR2B—skin of body—Crohn's disease	0.000126	0.0407	CbGeAlD
Ergotamine—ADRA1A—epithelium—Crohn's disease	0.000109	0.0354	CbGeAlD
Ergotamine—HTR2B—digestive system—Crohn's disease	0.000101	0.0326	CbGeAlD
Ergotamine—ADRA1A—lymphoid tissue—Crohn's disease	8.42e-05	0.0273	CbGeAlD
Ergotamine—ADRA2A—mammalian vulva—Crohn's disease	7.21e-05	0.0233	CbGeAlD
Ergotamine—HTR2A—epithelium—Crohn's disease	7.07e-05	0.0229	CbGeAlD
Ergotamine—CYP1A2—digestive system—Crohn's disease	6.88e-05	0.0223	CbGeAlD
Ergotamine—HTR2A—smooth muscle tissue—Crohn's disease	6.81e-05	0.022	CbGeAlD
Ergotamine—HTR2B—lymph node—Crohn's disease	5.75e-05	0.0186	CbGeAlD
Ergotamine—HTR2A—digestive system—Crohn's disease	5.38e-05	0.0174	CbGeAlD
Ergotamine—SLC6A2—lymph node—Crohn's disease	5.11e-05	0.0165	CbGeAlD
Ergotamine—CYP3A4—digestive system—Crohn's disease	4.98e-05	0.0161	CbGeAlD
Ergotamine—ABCB1—epithelium—Crohn's disease	4.63e-05	0.015	CbGeAlD
Ergotamine—ABCB1—mammalian vulva—Crohn's disease	4.02e-05	0.013	CbGeAlD
Ergotamine—ADRA2A—lymph node—Crohn's disease	3.61e-05	0.0117	CbGeAlD
Ergotamine—ABCB1—lymphoid tissue—Crohn's disease	3.57e-05	0.0115	CbGeAlD
Ergotamine—ABCB1—digestive system—Crohn's disease	3.52e-05	0.0114	CbGeAlD
Ergotamine—ABCB1—lymph node—Crohn's disease	2.01e-05	0.00651	CbGeAlD
Ergotamine—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	1.7e-05	0.000213	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—TYK2—Crohn's disease	1.69e-05	0.000212	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PTGER4—Crohn's disease	1.69e-05	0.000211	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	1.68e-05	0.000211	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—RASGRP1—Crohn's disease	1.67e-05	0.00021	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	1.67e-05	0.000209	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—TYK2—Crohn's disease	1.66e-05	0.000207	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—UBE2D1—Crohn's disease	1.65e-05	0.000207	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—JAK2—Crohn's disease	1.65e-05	0.000206	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—JAK2—Crohn's disease	1.63e-05	0.000205	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—SOCS1—Crohn's disease	1.63e-05	0.000204	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—CXCL8—Crohn's disease	1.62e-05	0.000203	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GPX4—Crohn's disease	1.62e-05	0.000202	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—JAK2—Crohn's disease	1.61e-05	0.000202	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.61e-05	0.000201	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—RIPK2—Crohn's disease	1.6e-05	0.000201	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—RBX1—Crohn's disease	1.6e-05	0.0002	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—UBE2D1—Crohn's disease	1.6e-05	0.0002	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—UBE2D1—Crohn's disease	1.59e-05	0.000199	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—CXCL8—Crohn's disease	1.59e-05	0.000199	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	1.58e-05	0.000198	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—JAK2—Crohn's disease	1.58e-05	0.000198	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.58e-05	0.000198	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—RBX1—Crohn's disease	1.57e-05	0.000197	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	1.57e-05	0.000197	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL3—Crohn's disease	1.56e-05	0.000196	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TYK2—Crohn's disease	1.56e-05	0.000196	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GCKR—Crohn's disease	1.56e-05	0.000196	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PTGER4—Crohn's disease	1.56e-05	0.000195	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—TYK2—Crohn's disease	1.55e-05	0.000195	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	1.55e-05	0.000194	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	1.55e-05	0.000194	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	1.55e-05	0.000194	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	1.54e-05	0.000193	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	1.54e-05	0.000193	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	1.53e-05	0.000192	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—SMAD3—Crohn's disease	1.53e-05	0.000192	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—UBE2D1—Crohn's disease	1.52e-05	0.00019	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—JAK2—Crohn's disease	1.52e-05	0.00019	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—SOCS1—Crohn's disease	1.52e-05	0.00019	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	1.51e-05	0.00019	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—RASGRP1—Crohn's disease	1.51e-05	0.000189	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL3—Crohn's disease	1.51e-05	0.000189	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL3—Crohn's disease	1.5e-05	0.000188	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	1.5e-05	0.000188	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—SMAD3—Crohn's disease	1.5e-05	0.000188	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—CXCL8—Crohn's disease	1.49e-05	0.000187	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—JAK2—Crohn's disease	1.49e-05	0.000187	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—JAK2—Crohn's disease	1.48e-05	0.000186	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—RIPK2—Crohn's disease	1.47e-05	0.000185	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TYK2—Crohn's disease	1.47e-05	0.000185	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—CXCL8—Crohn's disease	1.47e-05	0.000184	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	1.46e-05	0.000183	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	1.45e-05	0.000182	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—TYK2—Crohn's disease	1.45e-05	0.000181	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—CXCL8—Crohn's disease	1.44e-05	0.000181	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL3—Crohn's disease	1.44e-05	0.00018	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	1.43e-05	0.000179	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL2RA—Crohn's disease	1.42e-05	0.000178	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—SMAD3—Crohn's disease	1.41e-05	0.000176	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	1.41e-05	0.000176	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—JAK2—Crohn's disease	1.41e-05	0.000176	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	1.4e-05	0.000176	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	1.39e-05	0.000174	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	1.39e-05	0.000174	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	1.39e-05	0.000174	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—CXCL8—Crohn's disease	1.39e-05	0.000174	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	1.38e-05	0.000173	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	1.38e-05	0.000173	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—FADS1—Crohn's disease	1.38e-05	0.000173	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—JAK2—Crohn's disease	1.37e-05	0.000172	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—SOCS1—Crohn's disease	1.37e-05	0.000172	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.36e-05	0.000171	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—CXCL8—Crohn's disease	1.36e-05	0.00017	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—RIPK2—Crohn's disease	1.36e-05	0.00017	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	1.35e-05	0.00017	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	1.35e-05	0.000169	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	1.34e-05	0.000167	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL3—Crohn's disease	1.32e-05	0.000166	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	1.32e-05	0.000166	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	1.32e-05	0.000166	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	1.32e-05	0.000165	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	1.32e-05	0.000165	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	1.31e-05	0.000164	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	1.31e-05	0.000164	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	1.31e-05	0.000164	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL3—Crohn's disease	1.3e-05	0.000163	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	1.3e-05	0.000163	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—IL6—Crohn's disease	1.29e-05	0.000162	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GPX4—Crohn's disease	1.29e-05	0.000162	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—CXCL8—Crohn's disease	1.28e-05	0.000161	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	1.28e-05	0.000161	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	1.28e-05	0.00016	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	1.26e-05	0.000158	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	1.26e-05	0.000158	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	1.26e-05	0.000158	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	1.26e-05	0.000158	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	1.26e-05	0.000158	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	1.25e-05	0.000157	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	1.25e-05	0.000157	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	1.25e-05	0.000157	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GCKR—Crohn's disease	1.25e-05	0.000156	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	1.25e-05	0.000156	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	1.23e-05	0.000155	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—IL6—Crohn's disease	1.22e-05	0.000153	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	1.22e-05	0.000152	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	1.21e-05	0.000152	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	1.21e-05	0.000151	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	1.2e-05	0.000151	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	1.2e-05	0.000151	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	1.2e-05	0.00015	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	1.2e-05	0.00015	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL3—Crohn's disease	1.19e-05	0.000149	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	1.18e-05	0.000148	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	1.16e-05	0.000146	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	1.16e-05	0.000145	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	1.15e-05	0.000144	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	1.15e-05	0.000144	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	1.15e-05	0.000143	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	1.14e-05	0.000143	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	1.14e-05	0.000143	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	1.14e-05	0.000143	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	1.14e-05	0.000142	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	1.14e-05	0.000142	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	1.12e-05	0.00014	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	1.12e-05	0.00014	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	1.11e-05	0.000139	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	1.1e-05	0.000138	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	1.1e-05	0.000137	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—STAT3—Crohn's disease	1.09e-05	0.000137	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	1.09e-05	0.000137	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	1.09e-05	0.000136	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	1.09e-05	0.000136	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	1.07e-05	0.000134	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—FADS1—Crohn's disease	1.06e-05	0.000133	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	1.06e-05	0.000133	CbGpPWpGaD
Ergotamine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.06e-05	0.000133	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	1.06e-05	0.000132	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	1.06e-05	0.000132	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	1.05e-05	0.000132	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	1.05e-05	0.000131	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	1.04e-05	0.000131	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	1.04e-05	0.00013	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	1.04e-05	0.00013	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	1.04e-05	0.00013	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—STAT3—Crohn's disease	1.03e-05	0.000129	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	1.02e-05	0.000128	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	1.02e-05	0.000127	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	1.01e-05	0.000126	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	1e-05	0.000126	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TYK2—Crohn's disease	9.98e-06	0.000125	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GPX4—Crohn's disease	9.96e-06	0.000125	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	9.91e-06	0.000124	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	9.86e-06	0.000124	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TYK2—Crohn's disease	9.78e-06	0.000122	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	9.66e-06	0.000121	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	9.64e-06	0.000121	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GCKR—Crohn's disease	9.62e-06	0.00012	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—JAK2—Crohn's disease	9.53e-06	0.000119	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	9.5e-06	0.000119	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	9.48e-06	0.000119	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	9.45e-06	0.000118	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—JAK2—Crohn's disease	9.33e-06	0.000117	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	9.29e-06	0.000116	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	9.28e-06	0.000116	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TYK2—Crohn's disease	9.18e-06	0.000115	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	9.13e-06	0.000114	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	8.97e-06	0.000112	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	8.94e-06	0.000112	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.9e-06	0.000112	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—JAK2—Crohn's disease	8.76e-06	0.00011	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	8.69e-06	0.000109	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	8.63e-06	0.000108	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	8.55e-06	0.000107	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	8.51e-06	0.000107	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	8.31e-06	0.000104	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—IL6—Crohn's disease	8.27e-06	0.000104	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	8.15e-06	0.000102	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—IL6—Crohn's disease	8.09e-06	0.000101	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	8e-06	0.0001	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.79e-06	9.76e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	7.72e-06	9.66e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IL6—Crohn's disease	7.64e-06	9.57e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—IL6—Crohn's disease	7.6e-06	9.53e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TYK2—Crohn's disease	7.45e-06	9.33e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	7.44e-06	9.32e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	7.41e-06	9.28e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	7.36e-06	9.22e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IL6—Crohn's disease	7.2e-06	9.02e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ALB—Crohn's disease	7.18e-06	9e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—JAK2—Crohn's disease	7.1e-06	8.9e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	7.09e-06	8.88e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	7.08e-06	8.86e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	7.07e-06	8.85e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—STAT3—Crohn's disease	6.99e-06	8.76e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—STAT3—Crohn's disease	6.85e-06	8.58e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	6.77e-06	8.48e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	6.72e-06	8.41e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TYK2—Crohn's disease	6.54e-06	8.19e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	6.48e-06	8.12e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	6.45e-06	8.08e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	6.43e-06	8.06e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—STAT3—Crohn's disease	6.43e-06	8.06e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	6.39e-06	8e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	6.3e-06	7.89e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PTGS2—Crohn's disease	6.28e-06	7.87e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—JAK2—Crohn's disease	6.24e-06	7.81e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	6.18e-06	7.74e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL6—Crohn's disease	6.17e-06	7.72e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	6.14e-06	7.69e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	6.13e-06	7.68e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	6.01e-06	7.53e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	5.98e-06	7.5e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	5.87e-06	7.36e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	5.85e-06	7.33e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	5.69e-06	7.13e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	5.6e-06	7.02e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	5.58e-06	7e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	5.49e-06	6.87e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL6—Crohn's disease	5.41e-06	6.78e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	5.4e-06	6.77e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	5.33e-06	6.67e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	5.22e-06	6.53e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—STAT3—Crohn's disease	5.21e-06	6.53e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	5.19e-06	6.5e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	5.1e-06	6.38e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ALB—Crohn's disease	4.97e-06	6.22e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	4.97e-06	6.22e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL6—Crohn's disease	4.88e-06	6.12e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	4.85e-06	6.07e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL6—Crohn's disease	4.78e-06	5.99e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—STAT3—Crohn's disease	4.58e-06	5.74e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	4.51e-06	5.64e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL6—Crohn's disease	4.49e-06	5.63e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	4.41e-06	5.53e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTGS2—Crohn's disease	4.35e-06	5.44e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL6—Crohn's disease	4.18e-06	5.24e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	4.1e-06	5.13e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ALB—Crohn's disease	3.97e-06	4.97e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL6—Crohn's disease	3.77e-06	4.73e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6—Crohn's disease	3.64e-06	4.56e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6—Crohn's disease	3.62e-06	4.54e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTGS2—Crohn's disease	3.47e-06	4.35e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6—Crohn's disease	3.47e-06	4.35e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6—Crohn's disease	3.2e-06	4.01e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6—Crohn's disease	3.15e-06	3.94e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	3.08e-06	3.86e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ALB—Crohn's disease	3.06e-06	3.83e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6—Crohn's disease	2.86e-06	3.59e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.68e-06	3.35e-05	CbGpPWpGaD
